Company Profiles

Find premium company profile research reports. Purchase and download high quality report analysis, company reports, and much more

DocStore Search:
Per Page: 152550
  • Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Primary Health Care Limited (PHC) is a healthcare service provider. The company offers a wide
    View Document
  • Hanmi Science Co., Ltd. (008930) - Financial and Strategic SWOT Analysis Review
    Hanmi Science Co., Ltd. (008930) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Hanmi Science Co., Ltd. (008930) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Hanmi Science Co., Ltd. (Hanmi Science) is a pharmaceutical company. The company operates
    View Document
  • Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis Review
    Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Jeil Pharmaceutical Co., Ltd. (Jeil) is a pharmaceutical company. The company offers
    View Document
  • Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review
    Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Dr. Reddy's Laboratories Limited (Dr. Reddy's) is a pharmaceutical ingredient co
    View Document
  • Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review
    Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Cipla Ltd. (Cipla) is a pharmaceutical company. The company develops and markets generic pharmaceutical
    View Document
  • Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review
    Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Harbin Pharmaceutical Group Co., Ltd. (HPGC) is a state controlled Sino-fore
    View Document
  • G.L. Pharma GmbH - Strategic SWOT Analysis Review
    G.L. Pharma GmbH - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    G.L. Pharma GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights G.L. Pharma GmbH (G.L. Pharma) is a pharmaceutical company. The company develops and markets drugs. Its products include Acelisino comp. forte, Acelisino comp. mite, Aclop, Adjuvin, Adjuvin, Aedon, Aglandin, Aleptan, Alcover, Allernon, Amlodilan, Amoxilan, Anaerobex, Androbloc, Anastrolan, Androfin film, Antiflat, Anxiolit forte, Ascalan, Ascorbisal, Atenolan, Bupensan, Calmolan, Candeblo plus, Capecel, and Ciflox. G.L. Pharma provides products in film-coated tablets, capsules, chewable tablets, ampoules, solutio
    View Document
  • KAEL-GemVax Co., Ltd. - Strategic SWOT Analysis Review
    KAEL-GemVax Co., Ltd. - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    KAEL-GemVax Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights KAEL-GemVax Co.,Ltd. (KAEL-GemVax) is a pharmaceutical products manufacturer. The company develops and commercializes vaccines for the treatment of cancer using its technology platform. Its products include cancer vaccine, anti-inflammation and GV1001. KAEL-GemVax conducts clinical trials in the fields of melanoma, liver cancer, lung cancer and pancreatic cancer. The company also conducts pre-clinical study in cachexia, renal disease and benign prostatic hyperplasia. It partners with Orion Clinical Services,
    View Document
  • New Zealand Pharmaceuticals Limited - Strategic SWOT Analysis Review
    New Zealand Pharmaceuticals Limited - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    New Zealand Pharmaceuticals Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights New Zealand Pharmaceuticals Ltd. (NZ Pharma) is a biotechnology service provider. The company extracts and purifies biochemicals from by-products of the New Zealand meat processing industry. Its products include cholic acid, dehydrocholic acid, methyl cholate, peracetylated mannosamine, sodium cholate, natural taurine, deoxycholic acid, glycocholic acid, bile salts, sodium cholate, sodium deoxycholate, peracetylated mannosamine, sialic acid and mixed bile acids. New Zealand Pharmaceuticals L
    View Document
  • China Nuokang Bio-Pharmaceutical Inc. - Strategic SWOT Analysis Review
    China Nuokang Bio-Pharmaceutical Inc. - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    China Nuokang Bio-Pharmaceutical Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights China Nuokang Bio-Pharmaceutical Inc. (China Nuokang) is a biopharmaceutical company. The company develops, manufactures and markets hematological and cardiovascular products. Its products include Baquting and Aiduo. China Nuokang’s Baquting is a hemocoagulase product that holds proteolytic enzyme batroxobin, which promotes the blood coagulation process. The company’s Aiduo is an injectible coronary vasodilator, which is used as a diagnostic agent in connection with myocardial perfusion imagi
    View Document
  • Fareva Holding - Strategic SWOT Analysis Review
    Fareva Holding - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Fareva Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Fareva Holding (Fareva) is a contract manufacturing company that produces and markets cosmetics, food, pharmaceuticals and home care, and industrial and food packaging products. Its cosmetic packaging products include tinplate and aluminum aerosols, plastic and aluminum tubes, perfume bottles, pots, refill pouches and doypacks, and pump bottles. Fareva offers packaging products for pharmaceutical products in forms such as sprays, sterile injectables, sterile ophthalmic forms, pastes, solid forms, semi-solid forms,
    View Document
  • Dexcel Pharma - Strategic SWOT Analysis Review
    Dexcel Pharma - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Dexcel Pharma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Dexcel Pharma (Dexcel) is a pharmaceutical company. The company develops and markets healthcare products. Its products include CETIRIZINE, ZYLLERGY, ALVORAN, BETAREN, DEFANAC, DICLOFENAC, DICLOFENAC ATID, ACERIDEX, ASPIRIN, Cadex, LOSARTAN, METOPROLOL ATID, IOMERON, IOPAMIRO, PerioChip, Cemidin, CIMETIDINE, and Daivobet. Dexcel develops formulations using proprietary, patent-protected, and drug delivery technologies. It offers products in the areas such as allergy, analgesics, cardiovascular, contra media, dental, d
    View Document
  • Summit Pharmaceuticals International Corporation - Strategic SWOT Analysis Review
    Summit Pharmaceuticals International Corporation - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Summit Pharmaceuticals International Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Summit Pharmaceuticals International Corporation (Summit Pharmaceuticals) is a pharmaceutical company. The company commercializes pharmaceuticals, food additives, cosmetics, quasi-drugs and medical devices. It provides services in research and development assistance to pharmaceutical companies ranging from the assistance with original drug research to the arranging of licensing, production. Summit Pharmaceuticals also imports and exports new drugs and diagnostic products. The compa
    View Document
  • Alkem Laboratories Ltd. - Strategic SWOT Analysis Review
    Alkem Laboratories Ltd. - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Alkem Laboratories Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Alkem Laboratories Ltd. (Alkem) is a pharmaceutical company. The company develops, manufactures, and markets pharmaceutical products in India and internationally. Its products include active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides services in the acute and chronic therapeutic segments with extensive brand share in the central nervous system, gastro-intestinal, anti-diabetic, anti-malarial, cardiovascular, immunosuppressants, and neutraceuticals segm
    View Document
  • immatics biotechnologies GmbH - Strategic SWOT Analysis Review
    immatics biotechnologies GmbH - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    immatics biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Immatics biotechnologies Gmbh (immatics) is a clinical stage biopharmaceutical company. The company undertakes the development of therapeutic drugs using novel technology for the treatment of cancer. It has developed peptide based active immunotherapy in the area of oncology drug development. Immatics is currently working on the development of new substances for a number of specific cancer types, which include a phase 3 clinical trial for kidney cancer. The company has active earlier programs in seve
    View Document
Per Page: 152550